The present invention discloses compounds of Formulae I and II, wherein the variables in Formulae I and II are defined as described herein. Also disclosed are pharmaceutical compositions containing such compounds and methods for using the compounds of Formulae I and II in the treatment of HCV infection.
申请公布号
HK1199454(A1)
申请公布日期
2015.07.03
申请号
HK20140113129
申请日期
2014.12.31
申请人
F. HOFFMANN-LA ROCHE AG
发明人
BRINKMAN, JOHN A.;LI, HONGJU;SARABU, RAMAKANTH;SO, SUNG-SAU